(Q43825089)

English

Phenotypic and kinetic analysis of effective simian-human immunodeficiency virus-specific T cell responses in DNA--and fowlpox virus-vaccinated macaques

scientific article published in July 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Phenotypic and kinetic analysis of effective simian-human immunodeficiency virus-specific T cell responses in DNA--and fowlpox virus-vaccinated macaques (English)

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

object named as

fowlpox virus

1 reference

based on heuristic

inferred from title

Stephen J. Kent

3

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

author name string

Ivan Stratov

1

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

C Jane Dale

2

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

language of work or name

0 references

publication date

1 July 2005

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

337

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

222-234

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.023

7 January 2021

HIV-specific CD8(+) T cells produce antiviral cytokines but are impaired in cytolytic function

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.023

7 January 2021

Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.023

7 January 2021

Eventual AIDS vaccine failure in a rhesus monkey by viral escape from cytotoxic T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.023

7 January 2021

Construction of recombinant fowlpox viruses carrying multiple vaccine antigens and immunomodulatory molecules.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.023

7 January 2021

Chimeric human papilloma virus-simian/human immunodeficiency virus virus-like-particle vaccines: immunogenicity and protective efficacy in macaques

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.023

7 January 2021

Efficacy of DNA and fowlpox virus priming/boosting vaccines for simian/human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.023

7 January 2021

Evaluation in macaques of HIV-1 DNA vaccines containing primate CpG motifs and fowlpoxvirus vaccines co-expressing IFN? or IL-12

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.023

7 January 2021

Subtype AE HIV-1 DNA and recombinant Fowlpoxvirus vaccines encoding five shared HIV-1 genes: safety and T cell immunogenicity in macaques

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.023

7 January 2021

HIV preferentially infects HIV-specific CD4+ T cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.023

7 January 2021

Rapid viral escape at an immunodominant simian-human immunodeficiency virus cytotoxic T-lymphocyte epitope exacts a dramatic fitness cost

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.023

7 January 2021

Reversion of CTL escape–variant immunodeficiency viruses in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.023

7 January 2021

HCV Persistence and Immune Evasion in the Absence of Memory T Cell Help

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.023

7 January 2021

Distinct pathogenic sequela in rhesus macaques infected with CCR5 or CXCR4 utilizing SHIVs.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.023

7 January 2021

Mucosal transmission and induction of simian AIDS by CCR5-specific simian/human immunodeficiency virus SHIV(SF162P3)

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.023

7 January 2021

Immunization of rhesus macaques with a DNA prime/modified vaccinia virus Ankara boost regimen induces broad simian immunodeficiency virus (SIV)-specific T-cell responses and reduces initial viral replication but does not prevent disease progression f

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.023

7 January 2021

CD4+ T cells are required for secondary expansion and memory in CD8+ T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.023

7 January 2021

Effector and memory T-cell differentiation: implications for vaccine development

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.023

7 January 2021

Evidence of Recombination between 3′ and 5′ LTRs in Macaques Inoculated with SIV DNA

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.023

7 January 2021

CD8alpha alpha memory effector T cells descend directly from clonally expanded CD8alpha +beta high TCRalpha beta T cells in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.023

7 January 2021

HIV evolution: CTL escape mutation and reversion after transmission

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.023

7 January 2021

Use of overlapping peptide mixtures as antigens for cytokine flow cytometry

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.023

7 January 2021

Vaccine protection against functional CTL abnormalities in simian human immunodeficiency virus-infected rhesus monkeys.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.023

7 January 2021

Cellular immune responses to HIV.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.023

7 January 2021

Challenges and opportunities for development of an AIDS vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.023

7 January 2021

Cytotoxic T-lymphocyte escape monitoring in simian immunodeficiency virus vaccine challenge studies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.023

7 January 2021

Quantitation of HIV-1-Specific Cytotoxic T Lymphocytes and Plasma Load of Viral RNA

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.023

7 January 2021

Correlates of immune protection in HIV-1 infection: what we know, what we don't know, what we should know

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.023

7 January 2021

Development and homeostasis of T cell memory in rhesus macaque

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.023

7 January 2021

Neutralizing antibody-independent containment of immunodeficiency virus challenges by DNA priming and recombinant pox virus booster immunizations

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.023

7 January 2021

Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.023

7 January 2021

Two subsets of memory T lymphocytes with distinct homing potentials and effector functions

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.023

7 January 2021

Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.023

7 January 2021

Analysis of pigtail macaque major histocompatibility complex class I molecules presenting immunodominant simian immunodeficiency virus epitopes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.023

7 January 2021

Vaccines and vaccine strategies against HIV.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.023

7 January 2021

Lysis of HIV-1-infected cells and inhibition of viral replication by universal receptor T cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.023

7 January 2021

Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.023

7 January 2021

based on heuristic

inferred from DOI database lookup

Association between virus-specific cytotoxic T-lymphocyte and helper responses in human immunodeficiency virus type 1 infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.023

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficient lysis of human immunodeficiency virus type 1-infected cells by cytotoxic T lymphocytes.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.023

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VIROL.2005.04.023

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43825089&oldid=2128148476"